Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 0.45% | 166.93 | 0.7% | $1253.55m | |
| LLY | Eli Lilly & Co. | 0.18% | 311.43 | 1.1% | $814.08m | |
| BMY | Bristol-Myers Squibb Co. | -0.73% | 70.77 | 1.0% | $778.85m | |
| PFE | Pfizer Inc. | -1.10% | 44.08 | 0.9% | $769.71m | |
| ABBV | AbbVie, Inc. | 0.04% | 143.06 | 1.9% | $735.85m | |
| MRK | Merck & Co., Inc. | -0.81% | 86.80 | 0.7% | $691.58m | |
| AZN | AstraZeneca Plc | -3.07% | 54.58 | 1.0% | $397.16m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | -0.95% | 200.78 | 8.2% | $207.03m | |
| NVS | Novartis AG | -1.47% | 76.01 | 0.2% | $201.13m | |
| GBT | Global Blood Therapeutics, Inc. | 0.03% | 67.99 | 5.4% | $199.71m | |
| GSK | GSK Plc | -2.13% | 29.37 | 0.3% | $192.16m | |
| NVO | Novo Nordisk A/S | -0.40% | 97.92 | 0.1% | $170.11m | |
| HZNP | Horizon Therapeutics Plc | 0.54% | 62.97 | 5.4% | $156.21m | |
| SGEN | Seagen Inc. | -0.96% | 139.20 | 5.7% | $152.48m | |
| SRPT | Sarepta Therapeutics, Inc. | -2.42% | 108.19 | 12.4% | $128.76m |
Company Profile
Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney diseases. The firm is also involved in the development and commercialization of drugs for the treatment of renal and metabolic disorders. Its products include Auryxia and Vadadustat. The company was founded by Joseph H. Gardner, John M. Rice, Michael E. Pape, Josh P. Fairbank, and Robert A. Shalwitz on February 27, 2007 and is headquartered in Cambridge, MA.